Search

everythinglearnresearchcommunity

for

Search:↓

Understanding repigmentation mechanisms in vitiligo can improve treatments and patient outcomes.

Combining hydroxychloroquine and pimecrolimus can effectively treat hair loss from discoid lupus.

Iron deficiency might contribute to hair loss in women.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

A new surgical technique using vellus hair grafts effectively treated vitiligo without causing unwanted hair growth.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Some treatments, like corticosteroids and sensitizing agents, can help with alopecia areata, but more high-quality research is needed.

Pimecrolimus cream is not effective for treating alopecia areata.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

Laminin-511 may contribute to psoriasis by affecting skin cell growth and survival.

Indian men have 62.1% hair loss, mostly grade II vertex, and less extensive than other populations.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

Rituximab leads to longer remission and fewer side effects than cyclophosphamide.

Cyclosporine A promotes hair growth and prolongs the active growth phase in human hair follicles, but may work differently than in rodents.

Effective treatments for lichen planopilaris are unclear due to inconsistent results and a lack of strong research evidence.

Topical tacrolimus did not regrow hair in alopecia universalis patients.

Calcipotriol plus betamethasone with microneedling works better than tacrolimus for treating vitiligo.

Treatment with dutasteride, minoxidil, and artificial hair transplantation improved appearance but caused folliculitis.

Intralesional corticosteroids work best for mild alopecia areata, and DPCP works best for moderate to severe cases.

Pannexin 3 helps skin and hair growth by controlling a protein called Epiprofin.

Fractional laser treatment helped hair regrowth in patients with alopecia areata.

The document concludes that doctors should carefully consider off-label drug use in dermatology and always inform patients, while more research is needed on the safety and effectiveness of such practices.

Topical tofacitinib may effectively and safely regrow facial hair in some people with alopecia areata.

A boy with a rare skin condition and kidney disease improved with cyclosporine after steroids failed, suggesting a new treatment approach.

A new mix of anthralin and calcipotriene might help treat severe hair loss.

A man with Acrodermatitis continua did not get better with etanercept treatment, and his condition worsened, suggesting treatment effectiveness may vary by genetics and race.

Biodegradable microneedle patches help topical steroids work better for prurigo nodularis.

Various treatments exist for alopecia areata, but none are completely satisfactory; choice depends on age, disease extent, and preference.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.